These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 16836136
41. Phosphinic derivative of DTPA conjugated to a G5 PAMAM dendrimer: an 17O and 1H relaxation study of its Gd(III) complex. Lebdusková P, Sour A, Helm L, Tóth E, Kotek J, Lukes I, Merbach AE. Dalton Trans; 2006 Jul 28; (28):3399-406. PubMed ID: 16832488 [Abstract] [Full Text] [Related]
42. Synthesis, thermodynamics stability constant and relaxation properties of neutral Gd(III) complex with derivative from diethylene triamine pentaacetic acid and p-hydroxybenzoyl hydrazine. Zhang DW, Yang ZY, Zhang SP, Yang RD. Chem Pharm Bull (Tokyo); 2006 Mar 28; 54(3):406-8. PubMed ID: 16508204 [Abstract] [Full Text] [Related]
45. Equilibrium and NMR studies on GdIII, YIII, CuII and ZnII complexes of various DTPA-N,N''-bis(amide) ligands. Kinetic stabilities of the gadolinium(III) complexes. Jászberényi Z, Bányai I, Brücher E, Király R, Hideg K, Kálai T. Dalton Trans; 2006 Feb 28; (8):1082-91. PubMed ID: 16474894 [Abstract] [Full Text] [Related]
46. Gold nanoparticles functionalised by Gd-complex of DTPA-bis(amide) conjugate of glutathione as an MRI contrast agent. Park JA, Reddy PA, Kim HK, Kim IS, Kim GC, Chang Y, Kim TJ. Bioorg Med Chem Lett; 2008 Dec 01; 18(23):6135-7. PubMed ID: 18938074 [Abstract] [Full Text] [Related]
47. Magnetic resonance imaging of contrast-enhanced polyelectrolyte complexes. Huang M, Huang ZL, Bilgen M, Berkland C. Nanomedicine; 2008 Mar 01; 4(1):30-40. PubMed ID: 18201943 [Abstract] [Full Text] [Related]
48. Polyaspartamide gadolinium complexes containing sulfadiazine groups as potential macromolecular MRI contrast agents. Yan GP, Liu ML, Li LY. Bioconjug Chem; 2005 Mar 01; 16(4):967-71. PubMed ID: 16029038 [Abstract] [Full Text] [Related]
49. The gadolinium(III)-water hydrogen distance in MRI contrast agents. Caravan P, Astashkin AV, Raitsimring AM. Inorg Chem; 2003 Jun 30; 42(13):3972-4. PubMed ID: 12817950 [Abstract] [Full Text] [Related]
50. Synthesis and characterization of a Gd(III) based contrast agent responsive to thiol containing compounds. Carrera C, Digilio G, Baroni S, Burgio D, Consol S, Fedeli F, Longo D, Mortillaro A, Aime S. Dalton Trans; 2007 Nov 21; (43):4980-7. PubMed ID: 17992283 [Abstract] [Full Text] [Related]
51. Chitosan oligosaccharide based Gd-DTPA complex as a potential bimodal magnetic resonance imaging contrast agent. Huang Y, Cao J, Zhang Q, Lu ZR, Hua MQ, Zhang XY, Gao H. Magn Reson Imaging; 2016 Jan 21; 34(1):1-7. PubMed ID: 26485295 [Abstract] [Full Text] [Related]
52. The effect of ligand scaffold size on the stability of tripodal hydroxypyridonate gadolinium complexes. O'Sullivan B, Doble DM, Thompson MK, Siering C, Xu J, Botta M, Aime S, Raymond KN. Inorg Chem; 2003 Apr 21; 42(8):2577-83. PubMed ID: 12691564 [Abstract] [Full Text] [Related]
53. Facile synthesis of non-ionic dimeric molecular resonance imaging contrast agent: its relaxation and luminescence studies. Tanwar J, Datta A, Tiwari AK, Chaturvedi S, Ojha H, Allard M, Chaudary NK, Thirumal M, Mishra AK. Dalton Trans; 2011 Apr 07; 40(13):3346-51. PubMed ID: 21347458 [Abstract] [Full Text] [Related]
54. Flow-injection EPR investigation on OH radical scavenging activity of Gd(III) containing MRI contrast media. Mori Y, Watanabe R, Sakamoto S, Endo N, Nakano S, Kanaori K, Takashima H, Ohkawa M, Tajima K. J Med; 2004 Apr 07; 35(1-6):49-61. PubMed ID: 18084864 [Abstract] [Full Text] [Related]
55. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents. McMurry TJ, Parmelee DJ, Sajiki H, Scott DM, Ouellet HS, Walovitch RC, Tyeklár Z, Dumas S, Bernard P, Nadler S, Midelfort K, Greenfield M, Troughton J, Lauffer RB. J Med Chem; 2002 Aug 01; 45(16):3465-74. PubMed ID: 12139457 [Abstract] [Full Text] [Related]
56. Noncovalent binding of some new lipophilic gadolinium DTPA complexes to human serum albumin. A structure-affinity relationship. Laurent S, Vander Elst L, Henrotte V, Muller RN. Chem Biodivers; 2010 Dec 01; 7(12):2846-55. PubMed ID: 21161997 [Abstract] [Full Text] [Related]
57. Non-ionic bulky Gd(III) DTPA-bisamide complexes as potential contrast agents for magnetic resonance imaging. Bligh SW, Chowdhury AH, Kennedy D, Luchinat C, Parigi G. Magn Reson Med; 1999 Apr 01; 41(4):767-73. PubMed ID: 10332853 [Abstract] [Full Text] [Related]
58. Gd(III) complexes intercalated into hydroxy double salts as potential MRI contrast agents. Jin M, Spillane DE, Geraldes CF, Williams GR, Bligh SW. Dalton Trans; 2015 Dec 21; 44(47):20728-34. PubMed ID: 26568157 [Abstract] [Full Text] [Related]
59. Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity. Floyd WC, Klemm PJ, Smiles DE, Kohlgruber AC, Pierre VC, Mynar JL, Fréchet JM, Raymond KN. J Am Chem Soc; 2011 Mar 02; 133(8):2390-3. PubMed ID: 21294571 [Abstract] [Full Text] [Related]